Similar articles

• Ketamine for Treatment-Resistant Depression: a New Advocate.

  Pérez-Esparza R. Pérez-Esparza R. Rev Invest Clin. 2018;70(2):65-7. doi: 10.24875/RIC.18002501. Rev Invest Clin. 2018. PMID: 29718013
• Ketamine for Treatment-Resistant Depression: A Gateway to Novel Treatment Approaches.

  Limandri BJ. Limandri BJ. J Psychosoc Nurs Ment Health Serv. 2018 Oct 1;56(10):11-14. doi: 10.3928/02793695-20180920-02. J Psychosoc Nurs Ment Health Serv. 2018. PMID: 30278095
• Ketamine as an alternative treatment for treatment-resistant depression.

  Dowben JS, Grant JS, Keltner NL. Dowben JS, et al. Perspect Psychiatr Care. 2013 Jan;49(1):2-4. doi: 10.1111/ppc.12006. Epub 2012 Dec 30. Perspect Psychiatr Care. 2013. PMID: 23293991 Review. No abstract available.
• Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression.

  Pérez-Esparza R, Kobayashi-Romero LF, García-Mendoza AM, Lamas-Aguilar RM, Fonseca-Perezamador A. Pérez-Esparza R, et al. Acta Psychiatr Scand. 2019 Aug;140(2):182-183. doi: 10.1111/acps.13063. Acta Psychiatr Scand. 2019. PMID: 31251388 No abstract available.
• [Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression].

  Gosek P, Chojnacka M, Bieńkowski P, Swiecicki Ł. Gosek P, et al. Psychiatr Pol. 2012 Mar-Apr;46(2):283-94. Psychiatr Pol. 2012. PMID: 23214398 Review. Polish.